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Abstract
Significant quantities of antibiotics are used in all parts of the globe to treat diseases with bacterial origins. After ingestion,
antibiotics are excreted by the patient and transmitted in due course to the aquatic environment. This study examined
temporal fluctuations (monthly time scale) in antibiotic sources (ambulatory sales and data from a hospital dispensary) for
Lausanne, Switzerland. Source variability (i.e., antibiotic consumption, monthly data for 2006–2010) were examined in detail
for nine antibiotics – azithromycin, ciprofloxacin, clarithromycin, clindamycin, metronidazole, norfloxacin, ofloxacin,
sulfamethoxazole and trimethoprim, from which two main conclusions were reached. First, some substances –
azithromycin, clarithromycin, ciprofloxacin – displayed high seasonality in their consumption, with the winter peak being
up to three times higher than the summer minimum. This seasonality in consumption resulted in seasonality in Predicted
Environmental Concentrations (PECs). In addition, the seasonality in PECs was also influenced by that in the base wastewater
flow. Second, the contribution of hospitals to the total load of antibiotics reaching the Lausanne Wastewater Treatment
Plant (WTP) fluctuated markedly on a monthly time scale, but with no seasonal pattern detected. That is, there was no
connection between fluctuations in ambulatory and hospital consumption for the substances investigated.
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Introduction
Among the many types of pharmaceuticals, antibiotics receive
particular attention concerning their risk to the natural environ-
ment. Antibiotics are widely prescribed worldwide [1–3], and thus
are expected in receiving waters. Their presence in the aquatic
environment is of concern as they are potentially harmful to
organisms there. They are thought to foster bacterial resistance,
for example [4–7]. Not surprisingly, recent studies on the
occurrence of micropollutants in the environment include
antibiotics [8–14].
Several field campaigns have reported fluctuations of pharma-
ceutical concentrations in receiving waters [9,12,15,16], the
magnitude of which varies with location and substance. Roig
[17] reported an extensive overview of different field campaigns
focused on antibiotics and other pharmaceuticals in surface waters,
including Wastewater Treatment Plant (WTP) influent and
effluent. Since the temporal variation of pharmaceutical concen-
trations is a supplementary pressure on aquatic system preserva-
tion [18–20], understanding of such variations is an important
challenge in environmental assessment and management.
Antibiotics are present in both urban and rural environments.
For the latter, their concentrations are often driven by veterinary
use [14,21]. In urban settings, antibiotic concentrations in
wastewater result from ambulatory and hospital consumption
[22,23]. As a consequence, consumption data are needed to
estimate their concentration. Several studies attempted to estimate
wastewater pharmaceutical concentrations using sales data and the
Predicted Environmental Concentration Model (PEC) [22–27].
These studies were not focused on short-term fluctuations as they
considered only annual sales data. At present, no study has
considered seasonality in consumption of antibiotics in urban
settings.
Here, we first investigated seasonality of antibiotic concentra-
tions in wastewater based on monthly sales data and the PEC
model. Second, the fraction of antibiotics originating from
hospitals in the total load found in wastewater was examined,
again based on monthly consumption. The study considered nine
substances – azithromycin, ciprofloxacin, clarithromycin, clinda-
mycin, metronidazole, norfloxacin, ofloxacin, sulfamethoxazole
and trimethoprim – using data for the city of Lausanne,
Switzerland.
Materials and Methods
The WTP Basin
The study was conducted on the main WTP catchment of
Lausanne, Switzerland. This WTP serves 2009000 residents, and is
located at Vidy Bay, on the shore of Lake Geneva. The annual
total wastewater volume treated is approximately 40|106 m3.
The monthly water volume received at the WTP varies seasonally,
as can be seen in Figure 1, which illustrates the dynamics of the
monthly dry weather water volume at the Vidy Bay WTP inlet.
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These monthly dry weather wastewater data were provided by
Lausanne public authorities [28]. A seasonal trend can be
observed with higher volumes in summer than in winter. Similar
behaviour in WTP dry weather monthly flow volumes was
observed in other studies [29,30].
In our approach, we considered only hospitals or clinics
performing acute somatic treatments, as such establishments
dispense antibiotic prescriptions. Ten hospitals were identified,
for a total of 1600 beds. Their spatial distribution on the WTP
basin is illustrated in Figure 2.
Data Source
The study is based on data from ambulatory (pharmacies) sales
and hospital dispensaries. These data are considered as accurate
measures of consumption. Antibiotics are prescription drugs, and
are pathology-specific. Thus, the quantities prescribed should
match their consumption, and sales should match the amount
Figure 1. Monthly variations of dry weather flow at the Vidy
Bay WTP inlet. Flow is normalized to the annual mean flow, which is
18|106 m3. The monthly baseflow fluctuates between +40/225% of
the mean.
doi:10.1371/journal.pone.0053592.g001
Figure 2. Schematic view of the Vidy Bay WTP basin considered in this study. The main pipes of the collection system are illustrated with
bold lines. Hospitals and clinics for acute somatic treatment are located using grey pentagons. The total number of hospital beds in the basin is about
1600, which corresponds to a total of approximately 8 beds per 1000 inhabitant.
doi:10.1371/journal.pone.0053592.g002
Figure 3. Annual antibiotics sales estimated for the city of
Lausanne. Blue: ambulatory sales, red: total sales. From one year to the
next, the contribution of hospitals to the total load of antibiotics
consumed varies little. Likewise, ambulatory sales show little variation.
doi:10.1371/journal.pone.0053592.g003
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prescribed. For antibiotics, this connection is supported by the
high patient compliance in the case of antibiotic treatment [31].
This assumption was also retained by Le Corre et al. [27] for an
Australian case study. In consequence, consumption data in this
text will refer to sales data. Data sources were OFAC (Professional
Cooperative of Swiss Pharmacist: www.ofac.ch/, site last accessed
in May 2012) and CHUV (Centre Hospitalier Universitaire
Vaudois: www.chuv.ch/, site last accessed in May 2012) at
a monthly resolution for a five years period (2006–2010). Data
were obtained for nine antibiotics: azithromycin, ciprofloxacin,
clarithromycin, clindamycin, metronidazole, norfloxacin, oflox-
acin, sulfamethoxazole and trimethoprim. As trimethoprim and
sulfamethoxazole are co-prescribed as a single product, they were
in this study considered as a single compound named sulf/trim.
Downscaling of Ambulatory Antibiotic Sales
This study used 2006–2010 monthly sales data obtained for the
whole of the Canton of Vaud (670,000 inhabitants), as provided by
OFAC. These cantonal data were downscaled to the WTP
drainage area in two steps. First, data scaled to Lausanne were
obtained on a per-person base, assuming that consumption was
uniform over the canton. Second, since only 80% of pharmacies
are affiliated with OFAC, the data were corrected by a factor of 1/
0.8.
Upscaling of Hospital Antibiotic Usage
The monthly amounts of antibiotics dispensed at Vaud’s main
hospital (CHUV), located in Lausanne, were provided by the
CHUV pharmacy. Corresponding data for other Lausanne
hospitals could not be obtained. Total hospital consumption in
the Vidy Bay WTP basin was thus obtained from the CHUV data
by extrapolation to the number of beds using:
TOT~
CHUVconso
CHUVbeds
|TOTbeds: ð1Þ
In Eq.1, the CHUV consumption, CHUVconso, is normalized
by the number of CHUV beds, CHUVbeds (&750), and then
multiplied by the total number of hospital beds in the WTP
catchment, TOTbeds (&1600). This estimation integrates indirectly
the occupation rate of hospital beds, which is assumed to be
identical for all hospitals. Only hospitals with acute somatic
treatments were considered as they are likely to prescribe
antibiotics. CHUV data covered the same period as the
ambulatory antibiotics sales data. Description of antibiotics sales
datasets and data processing performed are summarized in
Table 1. Yearly total amounts of antibiotics used in the
ambulatory and hospital domains are summarized in Figure 3.
Predicted Environmental Concentration Model (PEC)
With widespread awareness of the issue of pharmaceuticals in
aquatic environments, public agencies like EMEA (European
Medicine Agency: www.ema.europa.eu, site last accessed in
March 2012) and FDA (Food and Drug Administration: www.
fda.gov, site last accessed in March 2012) have supported
development of predictive models of drug concentrations in
receiving waters. Applications of PEC models occur frequently
[25,26,32,33]. They require pharmaceutical consumption as an
input, with the output being a concentration, either in wastewater
or in natural waters. However, their use with monthly antibiotic
sales data has not been reported, and so here we adapted an
existing model [26]:
PEC~
M|fexcreta
V
ð2Þ
where PEC is the model output (monthly basis), i.e., the
concentration at the entrance of the WTP, V is the monthly
volume of wastewater reaching the WTP, M is the monthly mass
Table 1. Description of the antibiotics sales datasets.
Data Source Period Frequency Population concerned Data processing
Ambulatory OFAC 2006–2010 monthly Canton of Vaud Considered number of affiliated
pharmacies To downscale to the
Lausanne population
Hospital CHUV 2006–2010 monthly CHUV pharmacy Data were upscaled to the Lausanne
hospital and bed count
Ambulatory data sales were provided by OFAC for the Canton de Vaud. These data were downscaled to the Lausanne population based on pharmacy density. Hospital
data were extrapolated based on that provided by the CHUV considering the total number of hospital beds in Lausanne.
doi:10.1371/journal.pone.0053592.t001
Table 2. Excretion ratio (in % of amount consumed) in urine
for the different substances investigated.
Substance ATC
Excretion
ratio Source
Azithromycin J01FA10 12 Compendium SuisseH
Ciprofloxacin J01MA02 55 [2]
45–62 Compendium SuisseH
40 [41]
Clarithromycin J01FA09 25 [2]
Clindamycin J01FF01 10–20 Compendium SuisseH
Metronidazole P01AB01 40 [41]
Norfloxacin J01MA06 30 [2]
34 Compendium SuisseH
Ofloxacin J01MA01/
S01AX11
70 [41]
90 Compendium SuisseH
Sulfamethoxazole J01EE01 50 [2]
10–30 Compendium SuisseH
15 [42]
Trimethoprim J01EE01 50 Compendium SuisseH
When different values were found, the highest (worst case) was selected. Data
from the Compendium SuisseH can be found at http://www.kompendium.ch
(site last accessed in June 2012).
doi:10.1371/journal.pone.0053592.t002
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Figure 4. Seasonal fluctuations of antibiotic sales are shown in the left column. ambulatory (dark grey, left axis) and hospitals (light grey,
right axis). The data are normalized to the annual mean. On the right side of the figure, two columns of plots show periodograms for ambulatory sales
and hospital usage (left to right, respectively). The peak in the ambulatory-sales periodogram occurs at 0.08 month21, i.e., a period of 12 months for
these sales, indicated by the dashes.
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of antibiotic prescribed (sum of ambulatory and hospital prescrip-
tions), and fexcreta is the excretion ratio of the substance. Excretion
ratios for the list of substances investigated are presented in
Table 2.
In this study, we used the PEC model and monthly sales data to
investigate fluctuations of antibiotic concentrations in the WTP
influent. Monthly dry weather water volumes to the WTP were
used so that predicted concentrations were not distorted by any
dilution effects.
Results and Discussion
Periodicity in Consumption Cycle
Fluctuations in ambulatory antibiotic consumption are com-
pared with consumption of antibiotics in hospitals for the selected
substances. Figure 4 shows the monthly fluctuation of sales
normalized to the annual mean for both ambulatory and hospital
uses.
Three groups of substances emerge in Figure 4. The first group
is comprised of azithromycin, clarithromycin and ciprofloxacin.
These substances present clear seasonality of their ambulatory
sales data. The visual evidence of this seasonality is supported by
the periodogram of the ambulatory sales signal, with a dominant
frequency found at 0.083 month21, which corresponds to a 12-
months period. For azithromycin and clarithromycin, the highest
ambulatory sales in winter are around three times greater than the
minimum consumption observed during summer. Ciprofloxacin
ambulatory sales vary somewhat, between +20% of the annual
mean. Some seasonality was also observed for norfloxacin
ambulatory sales. This periodicity is absent for the hospitals uses.
The second group of substances is composed of ofloxacin,
clindamycin and sulf/trim. No seasonal fluctuation was found
for these antibiotics, either in the ambulatory sales data or in
hospital use. Finally, metronidazole was found to have a clear six
months period in its ambulatory sales.
Differences in seasonal cycles for antibiotics sales data can be
explained by considering their different therapeutic uses. The
substances with high seasonality in ambulatory sales (azithromy-
cin, clarithromycin and ciprofloxacin) are mainly prescribed for
airway infections (i.e., bronchitis and pneumonia) and infections
affecting the throat, nose and ears (pharyngitis, sinusitis, earache).
Figure 5. Ratio of hospital use to total use for the Lausanne WTP basin. Results are presented for clindamycin (green), trimethoprim (red)
and ciprofloxacin (blue). This ratio shows considerable volatility, depending on the month and substance considered.
doi:10.1371/journal.pone.0053592.g005
Table 3. Correlation coefficient of ambulatory and hospitals
sales.
Substance R
Azithromycin 0.02
Clarithromycin 0.27
Clindamycin 0.35
Ciprofloxacin 0.17
Metronidazole 0.17
Norfloxacin 0.58
Ofloxacin 0.03
Sulf/trim 0.01
R is the correlation coefficient. Consumption in hospitals and ambulatory do
not correlate.
doi:10.1371/journal.pone.0053592.t003
Table 4. Minimum/Mean/Maximum ratio (in %) of antibiotics
originating from hospitals found Lausanne wastewater,
calculated from 5 years of monthly consumption data.
Ratio (%)
Substance Minimum Mean Maximum
Azithromycin 0 6.5 33.2
Clarithromycin 7.7 15.2 41.9
Clindamycin 0 40.7 66.3
Ciprofloxacin 28.6 35.1 44.9
Metronidazol 18.3 34.5 46.6
Norfloxacin 0 2.7 10.0
Ofloxacin 0 0.6 2.2
Sulf/trim 16.2 30.5 51.8
doi:10.1371/journal.pone.0053592.t004
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The seasonality of the pathologies these substances treat explains
the observed seasonality in ambulatory sales data. The other
substances, for which there is no seasonal pattern in ambulatory
sales, have more diverse pathologies. In many cases, they are used
for non-seasonal diseases, typically infections of skin, bones, joints,
urinary-genital tract, stomach and peritonitis.
Hospital Consumption
Previous studies that evaluated the proportion of hospital-
sourced pharmaceuticals to the total WTP load typically used
a fixed figure [34–37]. This figure was often obtained from
comparison of measurements of hospital effluent and WTP
influent. Recently, Le Corre et al. [27] suggested calculating this
ratio from sales data, but the study is limited by the fact that
authors could only provide annual data. Yet, figure 5 shows that
monthly variability of this ratio can be significant.
Our data set do not reveal seasonal periodicity in the ratio of
antibiotics originating from hospitals. This is explained by the
seemingly random (i.e., aperiodic) behaviour of hospital antibiotic
consumption, which dominates over any periodic seasonal
consumption (Table 3). For some substances (e.g., ofloxacin and
norfloxacin), the monthly ratio remains constantly low, with little
fluctuation. On the other hand, it is difficult to draw any
conclusion on the monthly variation of the hospital ratio for other
substances. A specific case that can be identified is ciprofloxacin,
which has a high mean annual ratio of hospital use (35%), but low
monthly fluctuation (see Table 4 and Figure 5). In general, these
results suggest that hospital antibiotic use is largely disconnected
from non-hospital use, perhaps due to different protocols used for
hospital and non-hospital patients. Another possibility is that drugs
are used to treat different diseases in hospitals than in the
community.
Verlicchi et al. [38] summarized existing literature estimates of
ratios of hospital contribution to WTP effluent. Their summary
includes the studies of [34,36,37,39,40]. Their work confirms the
high spatial heterogeneity of the contribution of hospitals to the
total load in WTP influent. Our study shows that temporal
heterogeneity exists also. However, little variability was observed
from one year to the next in the contribution of hospitals to the
total antibiotic load consumed over the WTP basin (Figure 3),
whereas these fluctuations can be marked when observed at
a monthly time scale (Table 4). As a consequence, field campaigns
that aim to estimate hospital pharmaceutical contributions to
WTPs from comparison of measurements in hospital effluent and
WTP influent need to account for this variability in hospital
releases.
Modelled Concentrations
Here, PEC was calculated for WTP influent using Eq.2. Box
plots of the results built from the 5-y monthly total antibiotic
consumption for the Vidy Bay WTP catchment are presented in
Figure 6 for the eight substances investigated. Monthly water
volumes for computation of concentrations were obtained using
monthly dry weather wastewater coefficients (see Figure 1).
As presented in Figure 1, monthly dry weather wastewater flow
at the WTP inlet follows a periodic fluctuation (+40/225%
around annual mean). Seasonality was also observed for
consumption of some antibiotics above, in particular for
Figure 6. Computed monthly PEC at WTP inlet (one box per month). Each box was obtained from five monthly total sales data (total of 5 y of
data available, giving 5 sets of each month). The red line locates the median of the five months considered. Upper and lower box limits correspond to
the 75th and 25th percentiles, respectively. Upper and lower whiskers correspond to the last datum being within 1.5IQR of the higher and lower
quartile, respectively. IQR is the interquartile range, i.e., the difference between the upper and lower quartiles.
doi:10.1371/journal.pone.0053592.g006
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azithromycin, azithromycin, clarithromycin and ciprofloxacin.
However, antibiotic consumption and wastewater flow tend to be
out of phase. Antibiotic consumption is generally higher in winter
and lower in summer, whereas flow of wastewater is lower in
winter and higher in summer. This leads to an increase in the
amplitude of the concentration variation predicted at the WTP
inlet. The maximum seasonal effect of consumption on PEC is
observed for clarithromycin, with a maximum concentration
predicted in January around four times greater than the minimum
expected in August. This suggests that seasonality in drug
consumption alone does not explain the observed fluctuations in
pharmaceutical concentrations [9,12,15,16]. As a consequence,
this fluctuation would be equally present for all sort continuous
(not rain-driven) urban sources of pollution (ammonium, cleaning
products, etc.).
The PEC model used in this study is obviously limited by the
fact that it is built upon the strong assumption of conservative mass
transfer of substances from excretion to the WTP entrance. Yet,
this type of modelling approach is used often in risk prioritization
studies [25–27,32,33]. Typically, the PEC obtained from annual
data is compared to a threshold effect value (for instance, the
Predicted No Effect Concentration: PNEC). The substance is
considered as a risk if the threshold value is exceeded. However,
we highlighted in this study that several substances could show
sizable fluctuations in their environmental concentrations, due to
the combination of patterns that govern consumption and flow at
the monthly time scale. These fluctuations will affect directly the
results of the existing risk assessment methodologies. Indeed, it is
now generally established that the risk of a substance does not
depend solely on its average concentration but also on its
concentration dynamics, which has so far not been considered
[19,20].
Conclusion
In conclusion, this study has revealed important facts regarding
antibiotic consumption as a source of environmental pollution.
Some antibiotics have clear seasonal ambulatory consumption
depending on their therapeutic use. Seasonality was not evident in
hospital consumption. The contribution of hospitals to the total
load of substances reaching the WTP is strongly dependent on
time scale considered. The seasonality of ambulatory antibiotic
prescriptions can be used to infer seasonality in concentrations at
the WTP inlet. Yet, the variability of wastewater flow should also
be considered. Seasonality in wastewater flow was found to be out-
of-phase with the antibiotic fluctuation, leading to an increased
amplitude of concentration fluctuations at the WTP. Prioritization
studies that assess the potential risk of antibiotics or other
pharmaceuticals for the environment should consider these
fluctuations in their approach.
The assessment of antibiotic concentrations into wastewater
from detailed sales data reduces cost and uncertainties that are
usually associated to field experimental campaigns. Generally,
however, detailed pharmaceutical sales data remains difficult to
obtain. To investigate the time scale (month, day, hour) that drives
concentration fluctuation of drugs in the environment, long-term
field experimental campaigns remain mandatory.
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